Position in ILMN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,694,661
+$1,378,967 QoQ
Shares Held
26,700
-0.7% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#255
of 937 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $12,609,280 across 6 Diagnostics & Research names. ILMN ranks #2 (37.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CSTL |
Castle Biosciences Inc
|
221,338 | $5,278,911 | |
| 2 | ILMN |
Illumina, Inc.
This page
|
26,700 | $4,694,661 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
2,750 | $1,456,372 | |
| 4 | BDSX |
Biodesix Inc
|
26,035 | $587,089 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
860 | $452,738 | |
| 6 | XGN |
Exagen Inc.
|
30,002 | $139,509 |
All Filings in ILMN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,694,661 | 26,700 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,315,694 | 26,900 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,528,204 | 26,900 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,573,687 | 27,100 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||